Osteal Therapeutics, Inc.

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

• David Thompson — Executive Officer / Director, DALLAS, TX
  23 other raises

  • TI Dental Fund II, LP $8.5M of $10.0M · 85.4%
  • PGIM Lending Fund (Foxtrot) (Rated Feeder Fund), L.P. $0 of —
  • SIOX, LLC $340K of $500K · 68.0%
  • CIM-BGV Affordable Housing Impact Fund I, L.P. $95.0M of —
  • TI Nexus CPA Fund, LP $0 of $10.0M · 0.0%
  • CIM Urban Income Investments Parallel - 2, L.P. $1.57B of —
  • CIM Commercial Lending REIT $1.9M of $2.5B · 0.1%
  • CIM Opportunity Zone Fund, L.P. $2.22B of —
  • Ulrich Media Inc. $0 of $100.0M · 0.0%
  • Medici Therapeutics, Inc. $14.8M of $14.8M · 100.0%
  • CIM UII Onshore, L.P. $1.57B of —
  • CIM UII Onshore EE, L.P. $325K of —
  • CMMTP-2, L.P. $1.27B of —
  • CMMTP-1, L.P. $1.27B of —
  • CMMT Partners, L.P. $1.27B of —
  • Rise Private Credit Fund, LLC $5.5M of $27.8M · 19.9%
  • TI Midwest Fund 5, LP $1.8M of $10.0M · 18.0%
  • North Haven Capital Partners VIII-A LP $627.9M of —
  • North Haven Capital Partners VIII U.S. Wealth Management Partners LP $865.1M of —
  • North Haven Capital Partners VIII SCSp $493.0M of —
  • North Haven Capital Partners VIII Non-U.S. Wealth Management Partners LP $411.9M of —
  • North Haven Capital Partners VIII LP $673.2M of —
  • MSCP VIII Employees LP $57.5M of —
• Erik Oros — Director, DALLAS, TX
  8 other raises

  • Athelas Investors II LLC $3.8M of $4.8M · 80.6%
  • GSP Radar Access Fund LLC $63.0M of $63.0M · 99.9%
  • GSP Osteal Access Fund III LLC $19.4M of $30.0M · 64.8%
  • GSP Thread Access Fund LLC $2.6M of $30.0M · 8.5%
  • GSP StubHub Access Fund LLC $14.9M of $300.0M · 5.0%
  • GSP Pienso Access Fund LLC $6.7M of $7.6M · 88.6%
  • GSP SafeHeal Access Fund LLC $125K of $3.0M · 4.2%
  • Athelas Investors LLC $10.7M of $22.7M · 47.0%
• Sonal Patel — Director, DALLAS, TX
• Martin Sands — Director, DALLAS, TX
• Rushu Luo — Director, DALLAS, TX
  1 other raise

  • Minnesota Medical Technologies Corp $8.3M of $17.0M · 48.7%
• Judson Cooper — Director, DALLAS, TX
• Biren Mehta — Director, DALLAS, TX
  1 other raise

  • Tempo Therapeutics, Inc. $14.0M of $14.5M · 96.6%
• David Cash — Director, DALLAS, TX
• Brian de Beaubien — Executive Officer / Director, DALLAS, TX
• Douglas Kohrs — Director, DALLAS, TX
  2 other raises

  • Vergent Bioscience, Inc. $18.7M of $32.0M · 58.4%
  • RESTOR3D, Inc. $84.8M of $94.8M · 89.5%

Placement agents

• No sales compensation reported — direct raise.